Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm
April 17, 2024 10:18 ET | KUEHN LAW, PLLC
Kuehn Law investigates potential claims related to proposed mergers of NS, NXPL, IP, and RXMD. Shareholders urged to contact for details.
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – NS, CTLT, SCX, EVBG
April 04, 2024 10:53 ET | Monteverde & Associates PC
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
ALERT: Juan Monteverde Encourages the Shareholders of TARO, BATL, NS, INBX to Take Action
January 24, 2024 17:21 ET | Monteverde & Associates PC
NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
December 13, 2023 08:30 ET | Quoin Pharmaceuticals, Inc.
Positive initial data and clean safety profile catalyze optimization planSize of both ongoing clinical trials significantly increasedLower dose eliminated from blinded trialDosing frequency changed to...